RE:RE:RE:Great potentialseSnowden, it seems you become more and more interested in ICO since your first post here in May 11, 2017. If ICO is a garbage as you said, why do you waste your time to stick on here recently? You said 10 years--Imnp fails to provide any updates to their trials for the drug. Really? Don't be fooling others. Just go to IMNP's website and read all the news/updates. Or go to ICO's website to read all the updates/presentation. Clearly, You are even not a shareholder. So no worry about ICO and go to play other penny stocks you like. Good luck.
eSnowden wrote:
Share price of ICO has less to do with luck & more to do with the current state of ICO. ICO-008 has been in phase 2 trials since 2008, 10 years--Imnp fails to provide any updates to their trials for the drug--& with Imnp valuation of $6million USD, it is safe to say that ICO-008 may be a failure. As far as ICO's lastest addition into their pipeline...results were pre-clinical, not even phase 1, much time & money for this one. With current finances expected to satisfy needs until Q2 this year, in reality ICO is in dire shape.